MNK

MNK Articles

Mallinckrodt PLC (NYSE: MNK) reported its fiscal fourth-quarter financial results before the markets opened on Monday. The company had $1.84 in earnings per share (EPS) on $882.4 million in revenue...
While by many traditional metrics these may not look like true values stocks to some investors, Jefferies has indeed found stocks that at current trading levels offer investors great value and upside...
The biotech companies 24/7 Wall St. has picked stood out from the rest with incredible gains or losses over the course of the past week.
Tuesday's top analyst upgrades, downgrades and initiations include AbbVie, Apple, Autodesk, JD.com, CyberArk, Dean Foods and Walt Disney.
Wednesday's top analyst upgrades, downgrades and initiations include Analog Devices, Intel, Oracle, Royal Dutch Shell, Twitter, Under Armour and Whiting Petroleum.
Did the stock market find a formal bottom last week? That is what investors must be wondering now.
ThinkstockMallinckrodt PLC (NYSE: MNK) has been making waves in the market recently related to its guidance and it has caught the attention of one key analyst. Oppenheimer weighed in on Mallinckrodt...
It may be impossible to ever know if a true bottom has ever been seen, but many investors love finding great companies where they feel that a sell-off has overly punished the share price.
A new research report from Jefferies highlights value stocks to buy this week. These four stocks have the biggest upside to the posted price targets.
24/7 Wall St. has already highlighted the worst performing S&P 500 stocks of 2015, and now wants to highlight the best performing S&P 500 stocks of 2015.
A new research report from Merrill Lynch features three top pharmaceutical companies, dubbed the “Irish 3-Pack.”
A new research note from Jefferies highlights three of their franchise pick stocks to buy.
These are the top analyst upgrades, downgrades and initiations covered by 24/7 Wall St. for Monday, September 22, 2014.
With the summer doldrums over, the stock market is starting to return to normal. We also saw some very large insider selling in a top European pharmaceutical stock.
ThinkstockInvestors love to see insiders at high corporate levels purchasing their own companies’ stock. That is particularly true if the stock has performed well and has traded to higher levels....